Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on January 7, 2009
J Am Soc Nephrol 20: 535-544, 2009
© 2009 American Society of Nephrology
doi: 10.1681/ASN.2008040377
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
ASN.2008040377v1
20/3/535    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ueno, T.
Right arrow Articles by Abdi, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ueno, T.
Right arrow Articles by Abdi, R.

BASIC RESEARCH

Divergent Role of Donor Dendritic Cells in Rejection versus Tolerance of Allografts

Takuya Ueno*, Katsunori Tanaka*, Mollie Jurewicz*, Takaya Murayama*, Indira Guleria*, Paolo Fiorina*, Jesus C. Paez*, Andrea Augello*, Andrea Vergani*, Masie Wong*, R. Neal Smith{dagger} and Reza Abdi*

* Transplantation Research Center, Renal Division, Brigham and Women's Hospital and Children's Hospital, and {dagger} Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

Correspondence: Dr. Reza Abdi, 221 Longwood Avenue, Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115. Phone: 617-732-7249; Fax: 617-732-5254; E-mail: rabdi{at}rics.bwh.harvard.edu

Received for publication April 11, 2008. Accepted for publication September 12, 2008.

Little is known about heart tissue/donor dendritic cells, which play a key role in mounting alloimmune responses. In this report, we focus on three primary features of donor dendritic cells: their generation, their trafficking after transplantation, and their role in regulating tolerance versus rejection. Using transgenic mice as donors of heart allografts enabled us to monitor trafficking of donor dendritic cells after transplantation. Donor dendritic cells rapidly migrated into secondary lymphoid tissues within 3 h of transplantation. We found that the chemokine receptor CX3CR1 regulates the generation of heart tissue dendritic cells constitutively. Compared with wild-type hearts, CX3CR1–/– hearts contained fewer dendritic cells, and heart allografts from CX3CR1–/– donors survived significantly longer without immunosuppression. Unexpectedly, though, co-stimulatory blockade with anti-CD154 or CTLA4-Ig induced long-term survival for wild-type heart allografts but not for CX3CR1–/– heart allografts. Increasing the dendritic cell frequency in CX3CR1–/– hearts by treatment with Flt3L restored the anti-CD154–induced prolongation of CX3CR1–/– heart allograft survival. Compared with wild-type donors, depleting transgenic donors of dendritic cells before heart transplantation also markedly worsened chronic rejection under anti-CD154 treatment. These data indicate the importance of the CX3CR1 pathway in the generation of heart tissue dendritic cells and the divergent role of tissue/dendritic cells in rejection versus tolerance.






HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673